![](/img/cover-not-exists.png)
Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review
Arts-de Jong, Marieke, de Bock, Geertruida H., van Asperen, Christi J., Mourits, Marian J.E., de Hullu, Joanne A., Kets, C. MarleenVolume:
61
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2016.03.009
Date:
July, 2016
File:
PDF, 496 KB
english, 2016